Screening was performed using the oCelloScope instrument as previously described (33). Bacteria were added to achieve starting inocula of 106 CFU/ml and a total volume of 200 μl in a 96-well microtiter plate. The bacteria were exposed to single antibiotics and combinations of polymyxin B and a second drug at the following concentrations: polymyxin B, 0.25, 0.5, 1, and 2 mg/liter; amikacin, 4, 16, and 128 mg/liter; aztreonam, 2, 8, and 64 mg/liter; cefepime, 2, 8, and 64 mg/liter; chloramphenicol, 1, 8, and 32 mg/liter; ciprofloxacin, 0.25, 2, and 8 mg/liter; fosfomycin, 8, 32, and 128 mg/liter; linezolid, 2, 8, and 16 mg/liter; meropenem, 2, 16, and 64 mg/liter; minocycline, 0.5, 4, and 16 mg/liter; rifampin, 1, 8, and 32 mg/liter; temocillin, 4, 16, and 64 mg/liter; thiamphenicol, 2, 8, and 32 mg/liter; and trimethoprim, 1, 4, and 8 mg/liter. The oCelloScope was placed in a 37°C incubator for 24 h, and five images were acquired for each well every 15 min. Focus was set using the bottom search function. All experiments were performed in duplicate.
The UniExplorer software (version 6.0) algorithms were used to calculate background corrected absorption (BCA) and segmentation and extraction of surface area (SESA). BCA at >8.0 at 24 h and a maximum SESA value (SESAmax) at >5.8 were applied as cutoff values, indicating a bacterial density of >106 CFU/ml in the wells after 24 h (33). If the 24-h BCA and/or SESAmax values were below the cutoffs with the combination but not with either of the single antibiotics at the same concentration, the combination was considered to show a positive interaction and was subjected to subsequent evaluation in time-kill experiments.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.